| Year and age at diagnosis, yr | No. of cases | No. of events | Relative survival, 1 yr; % (95% CI) | Relative survival, 5 yr; % (95% CI) | ||
|---|---|---|---|---|---|---|
| Cohort analysis: female | ||||||
| 1990–1994 | ||||||
| < 60 | 62 | 48 | 38.3 | (27.1–49.3) | 17.4 | (9.4–27.5) |
| 60–69 | 57 | 49 | 29.0 | (18.7–40.0) | 11.0 | (4.92–19.9) |
| 70–79 | 38 | 37 | 14.4 | (7.2–24.0) | 0.4 | (0.01–4.3)* |
| ≥ 80 | 20 | 20 | 7.5 | (2.1–17.7) | 0.1 | (0.00–1.0) |
| 1995–1999 | ||||||
| < 60 | 56 | 38 | 49.2 | (36.1–61.0) | 25.9 | (15.1–38.2) |
| 60–69 | 73 | 56 | 54.5 | (43.2–64.5) | 19.23 | (11.3–29.0) |
| 70–79 | 79 | 72 | 22.5 | (15.3–30.6) | 6.1 | (2.3–12.8) |
| ≥ 80 | 21 | 19 | 25.3 | (12.0–41.5) | 10.1 | (1.9–29.0) |
| 2000–2004 | ||||||
| < 60 | 77 | 56 | 51.8 | (40.6–61.8) | 20.4 | (11.9–30.6) |
| 60–69 | 102 | 80 | 42.0 | (32.8–50.9) | 17.6 | (10.7–25.9) |
| 70–79 | 132 | 119 | 47.3 | (38.5–55.7) | 9.8 | (5.2–16.2) |
| ≥ 80 | 41 | 37 | 41.7 | (27.5–55.8) | 12.3 | (3.5–28.7) |
| 2005–2009 | ||||||
| < 60 | 125 | 65 | 70.9 | (62.2–78.0) | 27.7 | (18.3–37.9) |
| 60–69 | 113 | 81 | 54.3 | (44.8–62.8) | 19.4 | (11.9–28.3) |
| 70–79 | 150 | 120 | 51.5 | (43.4–59.1) | 12.9 | (7.4–20.1) |
| ≥ 80 | 87 | 81 | 40.8 | (30.4–51.2) | 4.8 | (0.8–15.6) |
| Cohort analysis: male | ||||||
| 1990–1994 | ||||||
| < 60 | 167 | 142 | 31.8 | (25.5–38.3) | 7.1 | (3.8–11.8) |
| 60–69 | 213 | 185 | 28.1 | (23.0–33.4) | 10.6 | (7.0–14.9) |
| 70–79 | 133 | 125 | 21.0 | (15.3–27.4) | 5.1 | (2.1–10.2) |
| ≥ 80 | 28 | 28 | 8.4 | (2.2–20.2) | 1.0 | (0.02–8.04)† |
| 1995–1999 | ||||||
| < 60 | 262 | 204 | 35.8 | (30.6–41.0) | 15.1 | (11.1–19.7) |
| 60–69 | 266 | 223 | 34.5 | (29.3–39.8) | 12.6 | (8.9–17.0) |
| 70–79 | 244 | 216 | 35.8 | (30.3–41.2) | 10.8 | (7.1–15.4) |
| ≥ 80 | 48 | 44 | 14.6 | (7.9–23.4) | 7.9 | (2.2–19.9) |
| 2000–2004 | ||||||
| < 60 | 468 | 296 | 52.5 | (48.1–56.7) | 27.5 | (23.3–31.9) |
| 60–69 | 349 | 278 | 44.0 | (38.9–48.9) | 17.3 | (13.4–21.7) |
| 70–79 | 334 | 290 | 47.6 | (42.4–52.7) | 13.3 | (9.6–17.7) |
| ≥ 80 | 78 | 75 | 30.5 | (21.0–40.8) | 3.7 | (0.7–11.7) |
| 2005–2009 | ||||||
| < 60 | 683 | 439 | 56.9 | (53.2–60.5) | 25.1 | (21.4–29.0) |
| 60–69 | 479 | 339 | 52.7 | (48.3–56.9) | 22.8 | (18.8–27.2) |
| 70–79 | 485 | 390 | 55.9 | (51.3–60.2) | 15.3 | (11.7–19.5) |
| ≥ 80 | 175 | 159 | 39.8 | (32.5–47.2) | 12.1 | (6.2–20.7) |
| Period analysis: estimates of 5-yr relative survival available in 2005–2009 | ||||||
| Female | ||||||
| < 60 | 125 | 65 | 70.9 | (62.2–78.0) | 26.6 | (16.8–37.4) |
| 60–69 | 113 | 81 | 54.3 | (44.8–62.8) | 19.9 | (12.4–28.7) |
| 70–79 | 150 | 117 | 51.5 | (43.4–59.1) | 12.2 | (6.7–19.6) |
| ≥ 80 | 87 | 73 | 40.8 | (30.4–51.2) | 8.2 | (2.0–21.3) |
| Male | ||||||
| < 60 | 683 | 421 | 56.9 | (53.2–60.5) | 27.6 | (23.8–31.5) |
| 60–69 | 479 | 329 | 52.7 | (48.3–56.9) | 21.7 | (17.6–26.2) |
| 70–79 | 485 | 372 | 55.9 | (51.3–60.2) | 13.9 | (10.2–18.2) |
| ≥ 80 | 175 | 149 | 39.8 | (32.5–47.2) | 8.9 | (3.4–18.4) |
Note: CI = confidence interval. *Relative survival, 4 yr. †Relative survival, 2 yr.